The Food and Drug Administration has found problems at an Indian factory that makes generic drugs for American patients, ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation, Inc. (HFI) and the Municipality of Malinao to launch a ...

We have audited the accompanying standalone financial statements of Glenmark Pharmaceuticals Limited (‘the Company), which comprise the Balance Sheet as at 31 March 2024, the Statement of Profit ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today. The company’s shares closed yesterday at $14.78. Easily identify stocks ...

Glenmark Pharmaceuticals announced that it has launched generic Empagliflozin, a widely recognized SGLT2 inhibitor, in India. The drug will be marketed under the brand name Glempa (Empagliflozin 10/25 ...

About Glenmark Pharmaceuticals Ltd. Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have started manufacturing key medicines for such diseases in the country.